ROOTS: A multicenter study in Belgium to evaluate the effectiveness and safety of liraglutide (Victoza®) in type 2 diabetic patients
Author:
Publisher
Elsevier BV
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference19 articles.
1. Standards of medical care in diabetes – 2014;American Diabetes Association;Diabetes Care,2014
2. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the study of diabetes (EASD);Inzucchi;Diabetes Care,2012
3. Achievement of goals in US diabetes care, 1999–2010;Ali;N Engl J Med,2013
4. for the UCL Study Group for Exenatide. One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice;Buysschaert;Diabetes Metab,2010
5. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus;Meier;Nat Rev Endocrinol,2012
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Real‐World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Final patient‐reported outcomes at 24 months;Diabetes, Obesity and Metabolism;2023-09-15
2. The real‐world observational prospective study of health outcomes with dulaglutide and liraglutide in patients with type 2 diabetes (TROPHIES): Final, 24‐month analysis of time to first significant treatment change, treatment persistence and clinical outcomes;Diabetes, Obesity and Metabolism;2023-09-12
3. Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world;Primary Care Diabetes;2022-12
4. Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect;Diabetes Therapy;2020-11-18
5. Diabetes-Related Effectiveness and Cost of Liraglutide or Insulin in German Patients with Type 2 Diabetes: A 5-Year Retrospective Claims Analysis;Diabetes Therapy;2020-09-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3